Kawasaki syndrome in the United States 1976 to 1980
- PMID:6823918
- DOI: 10.1001/archpedi.1983.02140290003001
Kawasaki syndrome in the United States 1976 to 1980
Abstract
Review of 523 confirmed cases of Kawasaki syndrome reported to the Centers for Disease Control (CDC), during the period from July 1976 through December 1980, disclosed a previously unrecognized seasonal variation, with a peak incidence between February and May. A significantly higher incidence in black children, compared with white children, was also noted. Earlier reports of a higher incidence in children younger than 5 years of age, males, and children of Asian ancestry were confirmed. Frequently reported complications included joint involvement (27%) and cardiac abnormalities (22%); 1.2% of patients died. Four outbreaks (mean duration, 3.8 months) were investigated by the CDC, but no evidence of person-to-person transmission or a point source of exposure was found. These data suggest that some cases may be caused by an exogenous agent or toxin that is most prevalent in the late winter and spring. In addition, host, environmental, or other cofactors are likely to be important determinants of susceptibility.
Similar articles
- National surveillance of Kawasaki disease.Morens DM, Anderson LJ, Hurwitz ES.Morens DM, et al.Pediatrics. 1980 Jan;65(1):21-5.Pediatrics. 1980.PMID:7355030
- Mucocutaneous lymph node syndrome in North Louisiana: review of 15 cases.Black CA, Bocchini JA Jr, Everist J.Black CA, et al.South Med J. 1983 Mar;76(3):290-5. doi: 10.1097/00007611-198303000-00005.South Med J. 1983.PMID:6828894
- Mucocutaneous lymph node syndrome in a young adult.Lee TJ, Vaughan D.Lee TJ, et al.Arch Intern Med. 1979 Jan;139(1):104-5.Arch Intern Med. 1979.PMID:760673
- [Mucocutaneous lymph node syndrome or Kawasaki disease].Zulaíca D, Ruíz M, Alba A, Higes A, Damiano A.Zulaíca D, et al.Rev Clin Esp. 1981 Nov 30;163(4):217-20.Rev Clin Esp. 1981.PMID:7038786Review.Spanish.No abstract available.
- Kawasaki disease in the United States.Morens DM, O'Brien RJ.Morens DM, et al.J Infect Dis. 1978 Jan;137(1):91-3.J Infect Dis. 1978.PMID:342638Review.No abstract available.
Cited by
- A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan.Nakamura Y, Yanagawa H.Nakamura Y, et al.Eur J Pediatr. 1996 Apr;155(4):303-7. doi: 10.1007/BF02002717.Eur J Pediatr. 1996.PMID:8777924
- Kawasaki disease--Indian perspective.Pendse RN, Bhandari H, Vats AK, Bhandari B.Pendse RN, et al.Indian J Pediatr. 2001 Aug;68(8):775-7. doi: 10.1007/BF02752421.Indian J Pediatr. 2001.PMID:11563255
- Seasonality and temporal clustering of Kawasaki syndrome.Burns JC, Cayan DR, Tong G, Bainto EV, Turner CL, Shike H, Kawasaki T, Nakamura Y, Yashiro M, Yanagawa H.Burns JC, et al.Epidemiology. 2005 Mar;16(2):220-5. doi: 10.1097/01.ede.0000152901.06689.d4.Epidemiology. 2005.PMID:15703537Free PMC article.
- Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison.Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, Singh-Grewal D, Bharath S, Sajjan S, Bayry J.Sharma C, et al.Nat Rev Rheumatol. 2021 Dec;17(12):731-748. doi: 10.1038/s41584-021-00709-9. Epub 2021 Oct 29.Nat Rev Rheumatol. 2021.PMID:34716418Free PMC article.Review.
- Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.Buda P, Friedman-Gruszczyńska J, Książyk J.Buda P, et al.Front Med (Lausanne). 2021 Nov 30;8:738850. doi: 10.3389/fmed.2021.738850. eCollection 2021.Front Med (Lausanne). 2021.PMID:34917629Free PMC article.Review.
MeSH terms
Related information
LinkOut - more resources
Medical